Centessa Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Centessa Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $44.17. The average 1-year stock price forecast is 11.09% higher than the current stock price, while the lowest is $38 (-4.43%) and the highest is $62 (+55.94%).

Price Target: $44.17 (+11.09%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$38	$44.17	$41	$62
Change	-4.43%	+11.09%	+3.12%	+55.94%

* Price targets were last updated on Apr 20, 2026.

Analyst Ratings

The average analyst rating for Centessa Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	12	13	8	3	3	3
Buy	3	3	1	1	1	1
Hold	0	0	4	9	9	8
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	16	13	13	13	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ami Fadia Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 11, 2026
Umer Raffat Evercore ISI	Evercore ISI	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Apr 20, 2026
Benjamin Burnett Wells Fargo	Wells Fargo	Hold Downgrades $42	Hold	Downgrades	$42	+5.63%	Apr 20, 2026
Danielle Brill Truist Financial	Truist Financial	Hold Downgrades $38	Hold	Downgrades	$38	-4.43%	Apr 13, 2026
Debjit Chattopadhyay Guggenheim	Guggenheim	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Apr 1, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 15.00M

-100.00%

from 15.00M

Revenue Next Year

20.00M

EPS This Year

-1.56

from -1.46

EPS Next Year

-1.79

from -1.56

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	6.85M	-	15.00M	-
Revenue Growth	-	-	-	-	-	-100.00%
Gross Profit	-	-	6.85M	-	15.00M	-
Gross Margin	-	-	100.00%	-	100.00%	90.00%
Operating Income	-139.33M	-210.28M	-171.28M	-201.06M	-207.69M	-251.16M
Net Income	-381.90M	-216.21M	-151.09M	-235.76M	-197.53M	-243.23M
EPS	-	-	-	-	-1.46	-1.56
Free Cash Flow	-82.08M	-108.73M	-96.60M	-75.19M	-138.54M	-229.55M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	-100.0%
Avg	-100.0%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-1.56
Avg	-1.56
Low	-1.56

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-